Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Return on Sales (2019 - 2025)

Historic Return on Sales for Madrigal Pharmaceuticals (MDGL) over the last 8 years, with Q3 2025 value amounting to 0.39%.

  • Madrigal Pharmaceuticals' Return on Sales rose 13300.0% to 0.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39%, marking a year-over-year increase of 63700.0%. This contributed to the annual value of 2.59% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Return on Sales of 0.39% as of Q3 2025, which was up 13300.0% from 0.2% recorded in Q2 2025.
  • Madrigal Pharmaceuticals' Return on Sales' 5-year high stood at 0.2% during Q2 2025, with a 5-year trough of 10.38% in Q2 2024.